HIV drugs may get new role in fighting cancer Reuters India Citi said it expected vicriviroc to re-enter clinical testing in combination with cancer immunotherapy as Merck explores its potential across multiple tumor types, including melanoma, colorectal, breast, prostate and liver cancer. Immunotherapy, which ... |